A striking finding from Laya Healthcare has put Ireland's relationship with artificial intelligence into sharp focus: six in ten people in the country now use AI platforms for mental health support. It is a number that would have seemed implausible just a few years ago, and it carries significant implications for healthcare, technology, and regulation.
The Scale of Adoption
The 60% figure represents a fundamental shift in how Irish people access wellbeing support. Traditionally, mental health services in Ireland have faced well-documented challenges: long waiting lists, limited availability outside urban centres, and persistent stigma around seeking help. AI platforms — whether chatbots, guided meditation apps, or conversational AI tools — appear to be filling gaps that the traditional system cannot.
This adoption rate is notably high by international standards and aligns with Microsoft's finding that Ireland ranks first in Europe for AI adoption. The Irish public, it seems, is not just comfortable with AI — it is actively integrating it into some of the most personal aspects of daily life.
The Opportunity
For Ireland's growing health-tech sector, this adoption rate represents both validation and a roadmap. Companies like Amethyst Care, which recently secured €100,000 in Enterprise Ireland Pre-Seed funding for its AI voice companion for older adults, are building products that address real and growing demand.
The broader Irish health-tech landscape is similarly active. Eolas Medical raised $12 million for its AI clinical knowledge platform. Aerska secured $60 million for RNA medicines targeting brain diseases. Deciphex, Fire1, and SynOx Therapeutics are all advancing in their respective niches. The ecosystem has depth.
Research Ireland's funding has generated eight new spin-outs from academic institutions, several with healthcare applications. The pipeline from university research to commercial product is functioning — a critical indicator of long-term sectoral health.
The Concerns
Rapid adoption of AI in mental health also raises important questions. Quality assurance is paramount: not all AI tools are created equal, and the difference between a well-designed, evidence-based platform and a poorly built chatbot can have real consequences for vulnerable users.
Data privacy is another critical consideration. Mental health conversations are among the most sensitive data a person can generate. Users need confidence that their interactions are protected, stored responsibly, and not used for purposes they did not consent to.
Ireland's Data Protection Commissioner, Michael McGrath, has been vocal about the need for stronger protections in digital spaces, particularly for children. As AI-based health tools become mainstream, these regulatory frameworks will need to keep pace.
What This Means for Business
The convergence of AI and healthcare represents one of the most significant market opportunities of the next decade — not just in Ireland, but globally. Irish companies and research institutions are well positioned to lead, given the country's strong talent base in both technology and life sciences.
For businesses developing digital products, the lesson is clear: AI adoption in Ireland is not theoretical. Consumers are ready, and in many cases ahead of the companies serving them. Meeting that demand with quality, secure, and compliant solutions is both a commercial opportunity and a responsibility.
At Umbak Technologies, we help businesses build digital health tools, patient-facing portals, and data-driven applications that meet the highest standards of security and privacy. If you are developing a health-tech product or integrating AI capabilities into your service, our team can help you ship with confidence.